Day: July 28, 2022

New migraine drug is about to be approved

Painkillers from three groups of active ingredients are currently available for the treatment of acute migraine headaches: non-steroidal anti-inflammatory drugs, triptans and rimegepant. With Lasmiditan,

Read More »